{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T02:20:44Z","timestamp":1785378044588,"version":"3.55.0"},"reference-count":30,"publisher":"Wiley","issue":"22","license":[{"start":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T00:00:00Z","timestamp":1469491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences (NCATS)","doi-asserted-by":"crossref","award":["KL2TR000136-09"],"award-info":[{"award-number":["KL2TR000136-09"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2016,11,15]]},"abstract":"<jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>Previous research has demonstrated that cancer survivors often fail to receive recommended care and also undergo unnecessary care; this reduces care quality and increases costs.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>This phase 2 trial randomized 100 stage 0 to IIIa breast cancer patients who had primary care providers within a large Massachusetts\u2010based hospital network (with accessible online records) to either coordinated follow\u2010up care (CC), which entailed a tailored survivorship care plan (SCP) and patient navigator calls every 3 months, or standard care (SC), which did not include an SCP or patient navigation, for 1 year after the completion of their last chemotherapy, surgery, or radiation treatment. The primary endpoint was the frequency of redundant examinations (&gt;1 breast\/chest wall examination per patient within any 30\u2010day period in the absence of a new breast or chest wall complaint) over the year of follow\u2010up. The total number of non\u2013plastic surgery visits in the year of follow\u2010up was a secondary endpoint.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Two patients (both on CC) were ineligible, and 2 patients (1 per arm) had a recurrence or died during follow\u2010up; this left 96 for analysis (47 in the CC arm and 49 in the SC arm). Twenty\u2010two of the 47 CC patients (47%; 95% confidence interval, 32%\u201062%) and 19 of the 49 SC patients (39%; 95% confidence interval, 25%\u201054%) had 1 or more redundant breast\/chest wall examinations during the year. The median number of non\u2013plastic surgery visits was 12 for CC patients and 8 for SC patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>Early\u2010stage breast cancer patients visit health care providers very frequently during their first year of follow\u2010up and often receive unnecessary breast\/chest wall examinations. An SCP and patient navigator calls did not reduce this surrogate for redundant care. <jats:bold><jats:italic>Cancer<\/jats:italic> 2016;122:3546\u20133554<\/jats:bold>. \u00a9 <jats:italic>2016 American Cancer Society<\/jats:italic><\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.30206","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T09:34:36Z","timestamp":1469525676000},"page":"3546-3554","source":"Crossref","is-referenced-by-count":13,"title":["Randomized phase 2 trial of a coordinated breast cancer follow\u2010up care program"],"prefix":"10.1002","volume":"122","author":[{"given":"Kathryn J.","family":"Ruddy","sequence":"first","affiliation":[{"name":"Department of Oncology Mayo Clinic Rochester Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of biostatistics and computational biology Dana\u2010Farber Cancer Institute Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily L.","family":"Baker","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology Dana\u2010Farber Cancer Institute Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Goldstein","sequence":"additional","affiliation":[{"name":"Department of Medicine Brigham and Women's Hospital Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin E.","family":"Mullaney","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology Dana\u2010Farber Cancer Institute Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence N.","family":"Shulman","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology University of Pennsylvania Philadelphia Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann H.","family":"Partridge","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology Dana\u2010Farber Cancer Institute Boston Massachusetts"},{"name":"Department of Medicine Brigham and Women's Hospital Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,7,26]]},"reference":[{"key":"e_1_2_8_2_1","volume-title":"Cancer Treatment and Survivorship Facts & Figures 2014\u20102015","author":"American Cancer Society","year":"2014"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-004-6497-9"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.03.060"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.2681"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-013-2041-y"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.8877"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601578"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.01.159"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2012.746468"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.5151"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/pon.2069"},{"key":"e_1_2_8_13_1","unstructured":"MariaHewitt SheldonGreenfield andEllenStovall. Committee on Cancer Survivorship: Improving Care and Quality of Life. National Cancer Policy Board. Institute of medicine and national research council of the national academies. The national academies press. Washington D.C. 2006."},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.3747\/co.21.1781"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.7540"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.6937"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-013-0327-1"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.505"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0936-6555(97)80055-6"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006199-199211000-00008"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-111-6-517"},{"issue":"3","key":"e_1_2_8_22_1","first-page":"1","article-title":"A randomized controlled trial of survivorship care plans among low\u2010income breast cancer survivors [abstract]","volume":"34","author":"Maly RC","year":"2016","journal-title":"J Clin Oncol"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1207\/s15430154jce2101s_4"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-12-201206190-00424"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-154-5-201103010-00307"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-9-200811040-00243"},{"key":"e_1_2_8_27_1","first-page":"91","article-title":"Preventive Services Task Force: screening for lipid disorders in adults: recommendations and rationale","volume":"102","author":"Berg AO","year":"2002","journal-title":"Am J Nurs"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-11-200912010-00005"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.8373"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-015-0443-1"},{"issue":"34","key":"e_1_2_8_31_1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1200\/jco.2012.30.34_suppl.164","article-title":"Quality of care among breast cancer (BC) survivors in the University of California (UC) Athena Breast Health Network [abstract]","volume":"30","author":"Ganz PA","year":"2012","journal-title":"J Clin Oncol"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.30206","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.30206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:14:20Z","timestamp":1760296460000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.30206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,26]]},"references-count":30,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2016,11,15]]}},"alternative-id":["10.1002\/cncr.30206"],"URL":"https:\/\/doi.org\/10.1002\/cncr.30206","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,26]]}}}